Notify me when Braden M. Leonard files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Common Stock, par value $0.001 per share | 8.5% | $21,288,120 | 7,216,312 | Leonard Braden Michael | 13 Dec 2024 | ||
| IKNA | Ikena Oncology, Inc. | Common Stock, par value $0.001 per share | 8.5% | $4,335,508 | +$470,890 | 4,090,102 | +12% | Leonard Braden Michael | 16 Jun 2025 |
| WHWK | Aadi Bioscience, Inc. | Common stock, par value $0.0001 per share | 5% | $3,749,900 | -$331,178 | 2,435,000 | 0% | Leonard Braden Michael | 05 Mar 2025 |
| Ikena Oncology, Inc. | Common Stock, par value $0.001 per share | 1.9% | 220,832 | Leonard Braden Michael | 25 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|